ENTRY       D10691                      Drug
NAME        Bempedoic acid (JAN/USAN/INN);
            Nexletol (TN)
PRODUCT     NEXLETOL (Esperion Therapeutics)
FORMULA     C19H36O5
EXACT_MASS  344.2563
MOL_WEIGHT  344.4861
CLASS       Hypolipidemic agent
             DG01946  Hypolipidemic agent
REMARK      ATC code: C10AX15
            Product: D10691<US>
EFFICACY    Antidyslipidemia
  DISEASE   Heterozygous familial hypercholesterolemia [DS:H00155]
COMMENT     Treatment of dyslipidemia
TARGET      ACLY (ACL) [HSA:47] [KO:K01648]
  PATHWAY   hsa00020(47)  Citrate cycle (TCA cycle)
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             C CARDIOVASCULAR SYSTEM
              C10 LIPID MODIFYING AGENTS
               C10A LIPID MODIFYING AGENTS, PLAIN
                C10AX Other lipid modifying agents
                 C10AX15 Bempedoic acid
                  D10691  Bempedoic acid (JAN/USAN/INN) &lt;US&gt;
            USP drug classification [BR:br08302]
             Cardiovascular Agents
              Dyslipidemics, Other
               Bempedoic Acid
                D10691  Bempedoic acid (JAN/USAN/INN)
            Drug groups [BR:br08330]
             Hypolipidemic agent
              DG01946  Hypolipidemic agent
               D10691  Bempedoic acid
            Drug classes [BR:br08332]
             Cardiovascular agent
              DG01946  Hypolipidemic agent
               D10691  Bempedoic acid
            Target-based classification of drugs [BR:br08310]
             Enzymes
              Transferases (EC2)
               ATP citrate synthase
                ACLY (ACL)
                 D10691  Bempedoic acid (JAN/USAN/INN) &lt;US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D10691
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D10691
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D10691
DBLINKS     CAS: 738606-46-7
            PubChem: 254741652
            ChEBI: 149601
ATOM        24
            1   C6a C    11.4100  -16.6600
            2   C1d C    12.6224  -17.3600
            3   C1b C    13.8349  -16.6600
            4   C1b C    15.0473  -17.3600
            5   C1b C    16.2597  -16.6600
            6   C1b C    17.4722  -17.3600
            7   C1b C    18.6846  -16.6600
            8   C1c C    19.8971  -17.3600
            9   C1b C    21.1096  -16.6600
            10  C1b C    22.3220  -17.3600
            11  C1b C    23.5345  -16.6600
            12  C1b C    24.7469  -17.3600
            13  O6a O    10.1976  -17.3600
            14  C1a C    11.9101  -18.6423
            15  C1a C    13.3224  -18.5725
            16  O1a O    19.8971  -18.7600
            17  C1b C    25.9593  -16.6600
            18  C1d C    27.1717  -17.3600
            19  C6a C    28.3842  -16.6600
            20  O6a O    29.5966  -17.3600
            21  O6a O    28.3842  -15.2600
            22  O6a O    11.4100  -15.2600
            23  C1a C    26.4717  -18.5725
            24  C1a C    27.8717  -18.5725
BOND        23
            1     1   2 1
            2     2   3 1
            3     3   4 1
            4     4   5 1
            5     5   6 1
            6     6   7 1
            7     7   8 1
            8     8   9 1
            9     9  10 1
            10   10  11 1
            11   11  12 1
            12    1  13 1
            13    2  14 1
            14    2  15 1
            15    8  16 1
            16   12  17 1
            17   17  18 1
            18   18  19 1
            19   19  20 1
            20   19  21 2
            21    1  22 2
            22   18  23 1
            23   18  24 1
///
